Ohr Pharmaceutical, Inc. 10-Q


Exhibit 32.1

Certification of Principal Executive Officer

Pursuant to 18 U.S.C Section 1350,

As Adopted Pursuant to Section 906 of the

Sarbanes-Oxley Act of 2002


Not Filed Pursuant to the Securities Exchange Act of 1934


In connection with the Quarterly Report of Ohr Pharmaceutical, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report” ), I, Irach Taraporewala, Principal Executive Officer, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: August 6, 2015  
/s/ Irach Taraporewala  
Name: Irach Taraporewala  
Title: Principal Executive Officer